REMDESIVIR CLEARED
- Antiviral drug Remdesivir has been cleared for treatment of COVID-19 patients “under emergency use”
- Remdesivir: It is a broad-spectrum antiviral medication
- As of 2020, remdesivir is being tested as a specific treatment for COVID-19
- Authorized for emergency use in the US, India, and approved for use in Japan for people with severe symptoms.
- It may shorten the time it takes to recover from the infection
- Remdesivir was originally created and developed by Gilead Sciences in 2009
- Remdesivir was originally developed to treat hepatitis C and was then tested against Ebola virus disease and Marburg virus disease
- Side effects may include liver inflammation and an infusion-related reaction with nausea, low blood pressure, and sweating.
- Remdesivir is the international nonproprietary name (INN) while the development code name was GS-5734
